Searched for
MISSION COVID SURAKSHA
Centre spent Rs 36,397 crore on procurement of COVID vaccines: GovtIndia's government allocated Rs 36,397.65 crore for providing free Covid vaccines to states and UTs. As of July 29, 2024, 220.68 crore dose...- Omicron-specific mRNA-based booster vaccine launchedIndia has developed its first indigenous mRNA vaccine, GEMCOVAC-OM, using platform technology developed by Gennova and funding from the Dep...
- DCGI grants Emergency Use Authorization to Gennova biopharma's Omicron-specific covid boosterThe mRNA-based vaccine was developed by Gennova Biopharmaceuticals using the indigenous platform technology, and supported under the Missio...
- Mukesh Ambani's Reliance Industries spends Rs 1,185 cr on CSR in FY22"Through FY 2021-22, RIL put social responsibility initiatives, health and well-being of communities at the top of its agenda," CSR report ...
- Hester Biosciences gets Rs 60 crore grant from govt to make Covaxin drug substanceHester said its Board has approved the execution of Grantin-Aid Letter Agreement for grant of Rs 60 crore in a phased manner to the company...
- With eye on tackling pandemic, science and tech ministry worked on boosting India's innovation value chain in 2021As variants of concern of COVID-19 emerged in the country, the Indian SARS-CoV-2 Genomics Consortium (INSACOG), studied over 80,000 genome ...
- Bharat Biotech gets nod for Phase 2/3 trials of intranasal Covid vaccineBBV154 is the first intranasal Covid-19 vaccine to undergo human trials in India. It has now received approval to conduct Phase 2 randomise...
- Bharat Biotech's Covid nasal vaccine gets regulator's nod for holding phase 2 clinical trialEarly stage trials of the vaccine candidate, BBV154, has been completed in subjects aged 18 to 60 years, and the doses were found to be wel...
- Monthly production capacity of Covishield, Covaxin planned to be increased: GovtFrom January 16 to August 5, 44.42 crore doses of Covishield were supplied by Serum Institute of India and 6.82 crore doses of Covaxin by B...
- Monthly production capacity of Covishield projected to increase to 120 million doses, Covaxin to 58 million doses: MinisterUnion Health Minister Mansukh Mandaviya was responding to a question on the current capacity to manufacture Covaxin and Covishield in the c...
- Reliance Foundation administers over 10 lakh COVID vaccine doses to RIL employees, family membersSoon after the government opened up vaccination for private companies, Reliance Foundation launched the vaccination drive in April, sources...
- 4 Covid vaccine candidates in human trial stage, 1 in pre-clinical stage, govt tells Rajya SabhaIn a written response to a question in the Rajya Sabha, Union Science and Technology Minister Jitendra Singh said Cadila Healthcare Ltd's D...
- RIL did not cut salaries of employees amid COVID: Nita Ambani at 44th AGMSpeaking at the 44th Annual General Meeting (AGM) of RIL, Nita Ambani said, "The Covid-19 pandemic is a humanitarian crisis. It has tested ...
- Scale up production capacity; government will provide all possible help: PM tells vaccine manufacturersHe also assured all possible support and smooth approval process for the vaccine candidates which are currently under trial phase. The heal...
- HGCO19 vaccine candidate: Gennova starts enrolment for Phase 1/2 human clinical trialsThe DBT said it has approved additional funding towards clinical studies of India's first of its kind' mRNA-based COVID-19 vaccine, HGCO19,...
- Indian vaccine makers tap Rs 900 crore government funding schemeIndian vaccine makers such as Serum Institute and Bharat Biotech have appealed to the government to fund the expansion of their vaccine man...
- Bharat Biotech seeks govt aid to boost Covid vaccine productionThe company has written to the Department of Biotechnology seeking Rs 100 crore to ramp up its manufacturing capacity.
- Healthcare service providers urge govt to increase healthcare spend in budget"The public spend in healthcare needs to increase from the current 1.2 per cent to at least 2.5 per cent of GDP in the next 3 years, much o...
- India looking to be self-reliant in development, production of vaccine against COVID-19While at least five pharmaceutical companies of India are engaged in vaccine development, Serum Institute in Pune has been chosen for mass ...
- The quest for a vaccine: Govt mulls 'Mission COVID Suraksha' with Rs 3,000-cr corpusThe proposed mission will also look to ensure that sufficient volumes are manufactured to meet India's COVID-19 vaccine requirement and to ...
Load More
